Compare GSK plc (GSK) vs Southwest Airlines Co (LUV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Southwest Airlines Co — how do they compare? GSK plc trades at $46.52 (market cap $91.88B), while Southwest Airlines Co trades at $41.71 (market cap $20.23B). The key difference: GSK plc is far larger — about 4.5× Southwest Airlines Co's market cap, and GSK plc pays the higher dividend (3.9%). Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and Southwest Airlines Co for 65 Days on average.
| GSK | LUV | |
|---|---|---|
Market Cap | $91.88B | $20.23B |
Volume | 7,730,529 | 14,560,422 |
Sector | Health | Industrials |
52-Week High | $61.18 | $54.80 |
52-Week Low | $43.24 | $29.67 |
Typical Hold Time | 93 Days | 65 Days |
Enterprise Value | $111.88B | $23.33B |
Dividend Yield | 3.9% | 1.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.45, down 1.21% with bearish technical signals. The company shows strong fundamentals with revenue growth to $32.67B in 2025 and consistent earnings beats. Valuation metrics appear reasonable with P/E of 14.89 and EV/EBITDA of 8.75. Recent developments include strategic oncology partnerships and a $750M cancer therapy acquisition, positioning for long-term growth despite near-term technical weakness.
GSK presents a mixed outlook with strong profitability and pipeline expansion offset by technical bearishness and HIV patent concerns. The company's 29.73% ROE and recent earnings outperformance support investment appeal, while the bearish moving average signal and competitive pressures warrant caution. Analyst consensus leans hold with 55% neutral rating, suggesting balanced risk-reward for long-term investors.
Southwest Airlines (LUV) trades at $41.15, down 1.37% on the day, amid a bearish technical signal despite recent earnings beats. The stock shows mixed fundamentals with a P/E of 25.85 and net income margin of 2.78%, while cash flow trends indicate a projected recovery in 2026. Recent news highlights the company's commercial transformation initiatives, including new fare structures and lounge plans, aiming to boost profitability.
Outlook remains cautiously optimistic with a consensus price target of $49.61, suggesting upside potential, though risks include volatile fuel costs and competitive pressures. The stock's valuation appears reasonable relative to sales, but investors should weigh near-term operational headwinds against long-term strategic gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Southwest Airlines Co
Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Read more on LUV →
